Full-Time

Senior Scientist

Immunotoxicology/Investigative Toxicology

Posted on 1/9/2025

MSD

MSD

Mid, Senior

H1B Sponsorship Available

North Wales, PA, USA

Hybrid work model requires three days in-office presence per week.

Category
Lab & Research
Life Sciences
Requirements
  • PhD in life science, such as Toxicology, Immunology, Biology, Biochemistry, Chemistry, or a related discipline AND 0-3+ years of postdoctoral or industry experience in immunotoxicology or immunology areas OR MS AND 4+ years of experience
  • Hand-on experiences in immunoassays which can include flow cytometry, ELISPOT, TDAR, or other immune cell function/activity assessments (blastogenesis assay, NK cell function, cytokine release, etc.).
  • Strong communication skills, with the ability to interact effectively with colleagues across multiple teams.
Responsibilities
  • Lead the design and implementation of fit-for-purpose in vitro and in vivo investigative tox plans to support immunotoxicity risk assessment and mechanistic investigations of new drug candidates.
  • Responsible for the generation and reporting of immunophenotyping, antibody responses, and various immune or hematopoietic- cellular-based functional assessments. Accurately record data from experiments, including observations, measurements, and sample details, in electronic laboratory notebooks.
  • Troubleshoot technical issues, provide data interpretation, and prepare high quality immunotoxicity assay/study reports.
  • Communicate effectively to Investigative Tox managers and stakeholders. Proactively identify gaps/risks in assay/study plans and inform the potential impact to team members.
  • Provide scientific leadership and immunotoxicology subject matter expertise at multidisciplinary team meetings.
  • Participate in external immunotoxicology consortia and symposia. Stay updated on the latest scientific research, regulatory guideline, and industry trends to guide informed decision and drive innovation in immunotoxicology safety assessment.

Company Stage

N/A

Total Funding

N/A

Headquarters

N/A

Founded

N/A

INACTIVE